All
FDA Approves Combination Treatment for Metastatic Prostate Cancer
May 24th 2018The Food and Drug Administration (FDA) approved a new formulation of Yonsa (abiraterone acetate) in combination with methylprednisolone as a treatment for men with metastatic castration-resistant prostate cancer (mCRPC), according to Sun Pharma, the company commercializing the treatment.
The Poetics of Prosthetic Bras
May 23rd 2018Even if being asymmetrical or flat is a valid choice for women who have undergone mastectomies, and that is how I usually feel best, there are no rules that say we should not wear a prosthetic bra now and then, or every single day, if it makes us smile or forget for a fleeting second that cancer can be disfiguring. There is no reason to feel self-conscious.
Patients and Caregivers Are on the 'Frontline' of Melanoma Monitoring
May 22nd 2018Recent research, conducted at NYU Langone Health and presented at the Oncology Nursing Society (ONS) Annual Congress, sought to find out how patients with melanoma perceived skin health education, and their willingness be involved in their own surveillance or a loved one’s.
Join the Conversation About Oncology Nurses
May 21st 2018Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.
Technology May Decrease Symptom Burden in Head and Neck Cancer Survivors
May 21st 2018Patients with head and neck cancer experienced a decrease in symptom severity after using mobile and sensor technology that allowed their health care providers to remotely monitor symptoms, according to research that will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.